Wells Fargo & Company Cor Medix Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Cor Medix Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 19,482 shares of CRMD stock, worth $111,047. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,482
Previous 17,981
8.35%
Holding current value
$111,047
Previous $76,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CRMD
# of Institutions
101Shares Held
16.9MCall Options Held
70.5KPut Options Held
358K-
Black Rock Inc. New York, NY3.55MShares$20.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$16.5 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl1.55MShares$8.84 Million0.04% of portfolio
-
Nomura Holdings Inc Tokyo, M01.42MShares$8.11 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.27MShares$7.25 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $235M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...